Rockwell Medical Statistics
Total Valuation
RMTI has a market cap or net worth of $25.68 million. The enterprise value is $16.37 million.
| Market Cap | 25.68M |
| Enterprise Value | 16.37M |
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RMTI has 39.47 million shares outstanding. The number of shares has increased by 15.65% in one year.
| Current Share Class | 39.47M |
| Shares Outstanding | 39.47M |
| Shares Change (YoY) | +15.65% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 14.67% |
| Float | 35.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | 0.35 |
| PB Ratio | 0.75 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | 14.73 |
| P/OCF Ratio | 9.72 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 9.32 |
Financial Position
The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.40.
| Current Ratio | 3.74 |
| Quick Ratio | 3.32 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | 8.19 |
| Interest Coverage | -4.26 |
Financial Efficiency
Return on equity (ROE) is -16.04% and return on invested capital (ROIC) is -6.35%.
| Return on Equity (ROE) | -16.04% |
| Return on Assets (ROA) | -5.40% |
| Return on Invested Capital (ROIC) | -6.35% |
| Return on Capital Employed (ROCE) | -10.12% |
| Weighted Average Cost of Capital (WACC) | 10.52% |
| Revenue Per Employee | $431,083 |
| Profits Per Employee | -$35,395 |
| Employee Count | 157 |
| Asset Turnover | 1.22 |
| Inventory Turnover | 13.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.53% in the last 52 weeks. The beta is 1.58, so RMTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.58 |
| 52-Week Price Change | -31.53% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 36.89 |
| Average Volume (20 Days) | 342,565 |
Short Selling Information
The latest short interest is 383,990, so 0.97% of the outstanding shares have been sold short.
| Short Interest | 383,990 |
| Short Previous Month | 491,297 |
| Short % of Shares Out | 0.97% |
| Short % of Float | 1.09% |
| Short Ratio (days to cover) | 1.42 |
Income Statement
In the last 12 months, RMTI had revenue of $67.68 million and -$5.56 million in losses. Loss per share was -$0.15.
| Revenue | 67.68M |
| Gross Profit | 11.55M |
| Operating Income | -4.81M |
| Pretax Income | -5.40M |
| Net Income | -5.56M |
| EBITDA | -2.65M |
| EBIT | -4.81M |
| Loss Per Share | -$0.15 |
Balance Sheet
The company has $23.89 million in cash and $14.39 million in debt, with a net cash position of $9.50 million or $0.24 per share.
| Cash & Cash Equivalents | 23.89M |
| Total Debt | 14.39M |
| Net Cash | 9.50M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 35.86M |
| Book Value Per Share | 0.91 |
| Working Capital | 27.08M |
Cash Flow
In the last 12 months, operating cash flow was $2.66 million and capital expenditures -$904,000, giving a free cash flow of $1.76 million.
| Operating Cash Flow | 2.66M |
| Capital Expenditures | -904,000 |
| Depreciation & Amortization | 2.16M |
| Net Borrowing | -1.16M |
| Free Cash Flow | 1.76M |
| FCF Per Share | $0.04 |
Margins
Gross margin is 17.07%, with operating and profit margins of -7.11% and -7.98%.
| Gross Margin | 17.07% |
| Operating Margin | -7.11% |
| Pretax Margin | -7.98% |
| Profit Margin | -7.98% |
| EBITDA Margin | -3.91% |
| EBIT Margin | -7.11% |
| FCF Margin | 2.60% |
Dividends & Yields
RMTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.65% |
| Shareholder Yield | -15.65% |
| Earnings Yield | -21.48% |
| FCF Yield | 6.79% |
Analyst Forecast
The average price target for RMTI is $3.00, which is 361.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.00 |
| Price Target Difference | 361.18% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 13, 2022. It was a reverse split with a ratio of 1:11.
| Last Split Date | May 13, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:11 |
Scores
RMTI has an Altman Z-Score of -7.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.33 |
| Piotroski F-Score | 4 |